Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oral7 International is a specialized healthcare company focused on the development and distribution of oral care products designed to manage dry mouth (xerostomia). The company's product range, including moisturizing toothpastes, mouthwashes, and gels, utilizes a unique formulation of natural enzymes—lysozyme, lactoferrin, and glucose oxidase—to mimic the protective functions of healthy saliva. These products are specifically formulated to restore the mouth's natural flora and pH balance, which is often disrupted in patients with Sjögren's syndrome, diabetes, or those undergoing medical treatments like chemotherapy. By reinforcing the mouth's natural defense system, Oral7 helps prevent tooth decay, gum disease, and bad breath associated with reduced salivary flow.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oral7 International.